ACHD Virtual 2020
Advancing the care for the most common, global, inborn defect
21 – 22 September 2020
The focus of the 2020 Meeting will be on Heart Failure and End-Stage CHD. As with previous years, there will be a plenary session in Pulmonary Arterial Hypertension in association with Congenital Heart Disease, plus two extended case discussion sessions.
Many patients with chronic and acute heart failure suffer from iron deficiency, which greatly affects their quality of life. It can reduce their exercise capacity and feeling of well-being.
Using oral iron products in heart failure is ineffective but newer intravenous iron products show good efficacy. They can improve six-minute walk test distance, peak oxygen consumption, New York Heart Association functional class and quality of life. It is also thought they help reduce hospitalisations for heart failure and cardiovascular mortality rates.
So it is important that we accurately diagnose iron deficiency in our heart failure patients and optimally treat it.
This webinar aims to update you with current thinking on iron deficiency in heart failure, its prevalence, clinical impact, current guidelines, treatment options and practical tips on service implementation. A practical demonstration will also be given on how to optimally infuse iv iron.
This webinar partially replaces some of the topics that would have been discussed at this year’s Annual Scientific Meeting.
The webinar can only be attended by healthcare professionals to whom it is offered free of charge. It is aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines.
Now in its 21st year, this long-standing and illustrious 1-day meeting will focus on innovative research, novel treatment options, and management of South Asian patients treated for diabetes within the UK health services.
This conference is free to attend for all healthcare professionals (HCPs) globally working within primary, intermediate, or secondary care settings and who manage South Asian patients with diabetes.
We have been listening to your feedback that you would like more case-based and practical learning so we are delighted to be able offer this new webinar, led by experts in the field, that will discuss the practical approach to the management of hyperkalaemia in patients with cardiorenal disease.
This will include the approach to broad-spectrum presentations, from those with potentially life-threatening hyperkalaemia through to the impact of high potassium on the use of prognostically important renin-angiotensin-aldosterone system (RAAS) inhibitors. Using case examples, they will discuss and guide on how to optimally manage such patients and avoid pitfalls that might have adverse consequences. Wherever possible, local pathways will be used and multidisciplinary discussion encouraged.
At the end of the webinar, delegates will have learned/contributed to multidisciplinary discussion around the following topics:
Start: Saturday 14th Nov 2020 - End: Monday 16th Nov 2020
Saturday 14th November 2020 - Monday 16th November 2020
Dallas, Texas, USA
Thursday 26th November 2020 - Friday 27th November 2020
Vision for heart failure
The BSH Annual Meeting will cover the latest scientific research, data and the best clinical practice in heart failure care. The conference will be taking place virtually using cutting edge technology bringing you multimedia content from a specialist, internationally renowned faculty.
This event will cover core areas of interest to all health professionals responsible for the care of heart failure patients.